Endocyte (see the April 20, 2010 LRTJ) recently announced interim results for its Phase II Ovarian Cancer study at the American Society of Clinical Oncology (ASCO) conference in Chicago, Illinois....
Contact us to learn the benefits of becoming a Lux member.
Or call us now
For North America (Boston Headquarters)
+1 (617) 502-5300
For EMEA (Amsterdam)
+31 20 280 7900
For APAC (Singapore)